In 2026, R&D speed is about learning faster, scaling responsibly and reducing risk in an increasingly complex system, says ...
Fast-tracked psychedelics hit a wall: why the FDA’s pause on psilocybin is an important check to ensure safety, rigor, and ...
1don MSN
Weed is actually ‘rarely justified’ to treat anxiety or depression, says major scientific review
A little green might not be a cure for the blues. New research suggests medical marijuana isn’t the mental health miracle ...
The largest review of medicinal cannabis to date found it doesn’t effectively treat anxiety, depression, or PTSD—despite millions using it for those reasons. Researchers warn it could even make mental ...
Why do trauma patterns repeat in relationships and behavior? Explore a new way to understand and address them.
EPA/REACH clearance, reactor expansion, compounding partners and defense qualification—plus valuation risks. See more.
Skincare tourism is growing as aesthetic treatments rise. SkinCeuticals enters Hainan with proven products like Advanced RGN-6, placing clinical skincare at the point of treatment.
The use of the agricultural input glyphosate may be one of the most hotly contested issues within public health right now.
Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.
1don MSN
Are Black Men Getting Botox Now?
Dr. Hank, founder of LuxMode Aesthetics & Wellness, explains why cosmetic treatments are gaining popularity with Black men now.
Exozymes are advanced enzymes enhanced through bioengineering and AI to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient ...
Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results